Blog Archive

Friday, December 18, 2020

VTGN plan to buy

 

  • Vistagen Therapeutics Inc (NASDAQ: VTGN) rose 18.8% to $1.10 in pre-market trading after gaining 11% on Thursday. VistaGen priced its 63 million share common stock offering at $0.92 per share.

No comments:

Post a Comment

SGNX

 

Labels